picture-profile-icon-male-icon-human-or-people-sign-and-symbol-free-vector-scaled-1-1.jpg

Berrin Tunca

lecturer at university (Prof. Dr.)
Uludag University, Medical Faculty
Turkey
WGs: WG1, WG3
Research Keywords: Cancer therapy, drug, tumor microenviroment, drug resistance
Personal Statement: My team and I are conducting studies to evaluate the therapeutic capabilities of various molecules in in vitro and in vivo cancer disease models. In these studies, we evaluate the activities of molecules with the potential for treatment in nanocarrier systems against cancer aggressiveness functionally and at genetic and epigenetic levels.
Tumor type: Colorectal, Brain, Stomach, Other
Models in use: In vitro, Ex vivo, In vivo
Immune cells of interest: T lymphocytes, Dendritic cells, Monocytes/macrophages, NK cells
Seeking: organoid imaging
Offering: disease models, drug resistance

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter